Femara and Diclofenac drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Femara and Diclofenac. Common interactions include dyspnoea exertional among females.

The phase IV clinical study analyzes what interactions people who take Femara and Diclofenac have. It is created by eHealthMe based on reports of 20 people who take Femara and Diclofenac from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 24, 2022

20 people who take Femara and Diclofenac together, and have interactions are studied.


What is Femara?

Femara has active ingredients of letrozole. It is often used in breast cancer. eHealthMe is studying from 17,692 Femara users for its effectiveness, alternative drugs and more.

What is Diclofenac?

Diclofenac has active ingredients of diclofenac. eHealthMe is studying from 30,013 Diclofenac users for its effectiveness, alternative drugs and more.

Number of Femara and Diclofenac reports submitted per year:

Femara and Diclofenac drug interactions.

Common Femara and Diclofenac drug interactions by gender *:

female:

  1. Dyspnoea exertional
  2. Gastric ulcer
  3. Haemoglobin decreased
  4. Intervertebral disc disorder
  5. Stress
  6. Thrombosis
  7. Tremor
  8. Alopecia
  9. Malaise
  10. Nervousness

male:

n/a

Common Femara and Diclofenac drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dehydration

50-59:

  1. Alopecia
  2. Anxiety
  3. Psychological trauma

60+:

  1. Dyspnoea exertional
  2. Gastric ulcer
  3. Intervertebral disc disorder
  4. Stress
  5. Thrombosis
  6. Tremor
  7. Malaise
  8. Nervousness
  9. Alopecia
  10. Dyspnoea

Common conditions people have *:

  1. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 30.00%
  2. High Blood Pressure: 6 people, 30.00%
  3. Breast Cancer Female: 6 people, 30.00%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 15.00%
  5. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.00%
  6. Neoplasm Malignant (cancer tumour): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Femara and Diclofenac?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Femara and Diclofenac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Femara interactions:

Browse all interactions between Femara and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Diclofenac interactions:

Browse all interactions between Diclofenac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on letrozole and diclofenac (the active ingredients of Femara and Diclofenac, respectively), and Femara and Diclofenac (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Femara and Diclofenac.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: